Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-Tk transduced T-cells.

• Prif Awduron: Eva Maria Weissinger (Awdur), Sylvia eBorchers (Awdur), Anna eSilvani (Awdur), Elena eProvasi (Awdur), Marina eRadrizzani (Awdur), Irene Katarina Beckmann (Awdur), Claudia eBenati (Awdur), Joerg eSchmidtke (Awdur), Wolfgang eKuehnau (Awdur), Patrick eSchweier (Awdur), Susanne eLuther (Awdur), Ivonne eFernadez-Munoz (Awdur), Gernot eBeutel (Awdur), Fabio eCiceri (Awdur), Chiara eBonini (Awdur), Arnold eGanser (Awdur), Bernd eHertenstein (Awdur), Michael eStadler (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2015-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Allogeneic stem cell transplantation (allo-HSCT) is one of the curative treatments for hematologic malignancies, but is hampered by severe complications, such as acute or chronic graft-versus-host-disease (aGvHD; cGvHD) and infections. CD34-selcetion of stem cells reduces the risk of aGvHD, but also...